Literature DB >> 16738155

Type 1 diabetes and pregnancy: trends in birth weight over 40 years at a single clinic.

F D Johnstone1, R S Lindsay, J Steel.   

Abstract

OBJECTIVE: To examine changes in perinatal mortality and birth weight of babies born to mothers with pregestational type 1 diabetes over 40 years in a single teaching hospital clinic.
METHODS: This was a retrospective survey of cases from the combined diabetes and obstetrics antenatal clinic at the Royal Infirmary of Edinburgh and Simpson Memorial Maternity Pavilion, Edinburgh, Scotland. Birth weight, standardized birth weight, and perinatal mortality were obtained from 643 singleton babies born after 28 weeks of gestation to mothers with pregestational type 1 diabetes between 1960 and 1999.
RESULTS: There was a dramatic improvement in perinatal mortality rate, falling from 225 (per 1,000 total births after 28 weeks of gestation) in the 1960s to 102 in the 1970s, 21 in the 1980s, and 10 in the 1990s (P < .001 for effect of birth year). In contrast, standardized birth weight (adjusted for sex, gestational age, and parity), which was significantly higher than the background population (+1.41 standard deviations above the population norm, P < .001) showed no significant change over time.
CONCLUSION: Changes in diabetic management and obstetric practice over the 40 years of our survey have resulted in enormous improvements in the outlook for offspring of mothers with diabetes. Somewhat surprisingly this has not been associated with a reduction in overgrowth of the fetus. LEVEL OF EVIDENCE: II-2.

Entities:  

Mesh:

Year:  2006        PMID: 16738155     DOI: 10.1097/01.AOG.0000218706.38886.10

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  8 in total

1.  Maternal type 1 diabetes reduces the risk of islet autoantibodies: relationships with birthweight and maternal HbA(1c).

Authors:  E Bonifacio; M Pflüger; S Marienfeld; C Winkler; M Hummel; A-G Ziegler
Journal:  Diabetologia       Date:  2008-05-08       Impact factor: 10.122

2.  Comment on: Hernandez et al. Patterns of glycemia in normal pregnancy: should the current therapeutic targets be challenged? Diabetes Care 2011;34:1660-1668.

Authors:  Edmond A Ryan
Journal:  Diabetes Care       Date:  2011-11       Impact factor: 19.112

Review 3.  Effect of screening and management of diabetes during pregnancy on stillbirths.

Authors:  Madiha Syed; Hasan Javed; Mohammad Yawar Yakoob; Zulfiqar A Bhutta
Journal:  BMC Public Health       Date:  2011-04-13       Impact factor: 3.295

4.  Risk of macrosomia remains glucose-dependent in a cohort of women with pregestational type 1 diabetes and good glycemic control.

Authors:  Katarzyna Cyganek; Jan Skupien; Barbara Katra; Alicja Hebda-Szydlo; Izabela Janas; Iwona Trznadel-Morawska; Przemysław Witek; Elżbieta Kozek; Maciej T Malecki
Journal:  Endocrine       Date:  2016-10-11       Impact factor: 3.633

5.  Diabetes and pregnancy: national trends over a 15 year period.

Authors:  Sharon T Mackin; Scott M Nelson; Joannes J Kerssens; Rachael Wood; Sarah Wild; Helen M Colhoun; Graham P Leese; Sam Philip; Robert S Lindsay
Journal:  Diabetologia       Date:  2018-01-11       Impact factor: 10.122

6.  Balancing weight and glucose in gestational diabetes mellitus.

Authors:  Edmond A Ryan
Journal:  Diabetes Care       Date:  2013-01       Impact factor: 19.112

7.  Effectiveness of continuous glucose monitoring in pregnant women with diabetes: randomised clinical trial.

Authors:  Helen R Murphy; Gerry Rayman; Karen Lewis; Susan Kelly; Balroop Johal; Katherine Duffield; Duncan Fowler; Peter J Campbell; Rosemary C Temple
Journal:  BMJ       Date:  2008-09-25

8.  Time trends in pregnancy-related outcomes among women with type 1 diabetes mellitus, 2004-2017.

Authors:  Sarit Helman; Tamarra M James-Todd; Zifan Wang; Andrea Bellavia; Jennifer A Wyckoff; Shanti Serdy; Elizabeth Halprin; Karen O'Brien; Tamara Takoudes; Munish Gupta; Thomas F McElrath; Florence M Brown
Journal:  J Perinatol       Date:  2020-06-02       Impact factor: 2.521

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.